Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice

Shengnan Zhou(Shandong Academy of Pharmaceutical Sciences), Lihua Zuo(IONICS Mass Spectrometry (Canada)), Yuanyuan Zhang(University of Nebraska–Lincoln), Jian Kang(Gansu Provincial Hospital), Jiuming He(Beijing Academy of Science and Technology), Liwei Liu(Zhengzhou University), Zhibo Zhang(Nanjing Drum Tower Hospital), Hanbing Li(Zhejiang University of Technology)
Frontiers in Pharmacology
January 11, 2023
10.3389/fphar.2022.1104954
Cited by 14

Related Papers

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
|Signal Transduction and Targeted Therapy|2021|403
Direct Magnetic Reinforcement of Electrocatalytic ORR/OER with Electromagnetic Induction of Magnetic Catalysts
|Advanced Materials|2020|279
Multifunctional flexible membranes from sponge-like porous carbon nanofibers with high conductivity
|Nature Communications|2019|237
Recent Advances of Porous Graphene: Synthesis, Functionalization, and Electrochemical Applications
|Small|2019|225
Fabrication of Flexible Mesoporous Black Nb<sub>2</sub>O<sub>5</sub> Nanofiber Films for Visible‐Light‐Driven Photocatalytic CO<sub>2</sub> Reduction into CH<sub>4</sub>
|Advanced Materials|2022|210